NCT02099461View on ClinicalTrials.gov

Effect of Denosumab on Cellular Biomarkers in the Human Breast

PHASE1CompletedINTERVENTIONAL

Enrollment

82

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Healthy Volunteer, Female, Breast

Interventions

DRUG

Denosumab

Single sucutaneous dose

PROCEDURE

Percutaneous core needle breast biopsy

Trial Locations (3)

33024

Research Site, Hollywood

33143

Research Site, Miami

90630

Research Site, Cypress

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY